Multiple myeloma--translation of trial results into reality

Lancet. 2016 Jul 9;388(10040):111-3. doi: 10.1016/S0140-6736(16)30954-0.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Boron Compounds / therapeutic use
  • Bortezomib / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic
  • Clinical Trials as Topic*
  • Cyclic N-Oxides
  • Drug Approval
  • Drug Discovery
  • Glycine / analogs & derivatives
  • Glycine / therapeutic use
  • Humans
  • Indolizines
  • Lactones / therapeutic use
  • Lenalidomide
  • Multiple Myeloma / drug therapy*
  • Oligopeptides / therapeutic use
  • Practice Guidelines as Topic
  • Pyridinium Compounds
  • Pyrroles / therapeutic use
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Boron Compounds
  • Bridged Bicyclo Compounds, Heterocyclic
  • Cyclic N-Oxides
  • Indolizines
  • Lactones
  • ONX 0912
  • Oligopeptides
  • Pyridinium Compounds
  • Pyrroles
  • elotuzumab
  • dinaciclib
  • daratumumab
  • Thalidomide
  • Bortezomib
  • marizomib
  • ixazomib
  • Lenalidomide
  • Glycine